Acute pancreatitis as a model of sepsis

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue SUPPL. A, 1998, Pages 51-63

  Wilson, Paul G ^a   Manji, Mavji ^b   Neoptolemos, John P ^b,c  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; PHOSPHOLIPASE A2; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR;

ACUTE DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; HEART EJECTION FRACTION; HEMODYNAMICS; HUMAN; INFLAMMATION; MULTIPLE ORGAN FAILURE; PANCREAS NECROSIS; PANCREATITIS; PATHOGENESIS; PATIENT; SEPSIS; SEPTIC SHOCK; SYNDROME DELINEATION; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

EID: 0031985590     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.suppl_1.51     Document Type: Conference Paper

References (104)

1. Young, L. S., Martin, W. J., Meyer, R. D., Weinstein, R. J. & Andersen, E. T. (1977). Gram-negative rod bacteremia: microbiologic, immunologie, and therapeutic considerations. Annals of Internal Medicine 86, 456-71
2. Perlino, C. A. & Rimland, D. (1985). Alcoholism, leukopenia and pneumococcal sepsis. American Review of Respiratory Disease 132,757-60.
3. Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A. et al. (1992). American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101,1644-55.
4. Sibbald, W. J., Doig, G. & Inman, K. J. (1995). Sepsis, SIRS and infection. Intensive Care Medicine 21, 299-301.
5. Willatts, S. M., Speller, D. C. E. & Winter, R. J. (1994). Incidence of Gram-negative bacteraemia in sepsis syndrome. Anaesthesia 49, 751-4.
6. Marshall, J. & Sweeney, D. (1990). Microbial infection and the septic response in critical surgical illness. Archives of Surgery 125, 17-23.
7. Alexander, H. R., Sheppard, B. C., Jenson, J. C., Langstein, H. N., Buresh, C. M., Venzon, D. et al. (1991). Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension and hypothermia of Gram-negative sepsis. Journal of Clinical Investigation 88, 34-9.
8. Kaplan, E., Dinarello, C. A., Wakabayashi, G., Burke, J. F., Connolly, R. S. & Gelfand, J. A. (1993). lnterleukin-1 pretreatment protects against endotoxin-induced hypotension in rabbits: association with decreased tumor necrosis factor levels. Journal of Infectious Diseases 167, 244-7.
9. Brady, A. J. B. & Poole-Wilson, P. A. (1993). Circulatory failure in septic shock. Nitric oxide: too much of a good thing? British Heart Journal 70, 103-5.
10. Dabrowski, A. & Gabryelewicz, A. (1994). Nitric oxide contributes to multiorgan oxidative stress in acute experimental pancreatitis. Scandinavian Journal of Gastroenterology 29, 943-8.
11. Stern, D. M., Bank, I., Nawroth, P. P., Cassineris, J., Kisiel, W., Fenton, J. W. et al. (1985). Self-regulation of procoagulant events on the endothelial cell surface. Journal of Experimental Medicine 162, 1223-35.
12. Nawroth, P. P., Bank, I., Handley, D., Cassimeris, J., Chess, L. & Stern, D. (1986). Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. Journal of Experimental Medicine 163, 1363-75.
13. Adams, D. H. & Shaw, S. (1994). Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 343, 831-6.
14. Giroir, B. P. (1993). Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade. Critical Care Medicine 21, 780-9.
15. Stuber, F., Petersen, M., Bokelmann, F. & Schade, U. (1996). A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Critical Care Medicine 24, 381-4.
16. Winslet, M. C., Hall, C., London, N. J. M. & Neoptolemos, J. P. (1992). Relation of diagnostic serum amylase levels to aetiology and severity of acute pancreatitis. Gut 33,982-6.
17. Ørstavik, T. B., Brandtzaeg, P., Nustad, K. & Pierce, J. V. (1980). lmmunohistochemical localization of kallikrein in human pancreas and salivary glands. Journal of Histochemistry and Cytochemistry 28, 557-62.
18. α). Journal of Biological Chemistry 264, 14927-34.
19. Chun, M. & Hoffmann, M. K. (1987). Intracellular cAMP regulates the cytotoxicity of recombinant tumor necrosis factor for L cells in vitro. Lymphokine Research 6, 161-7.
20. Spinas, G. A., Keller, U. & Brockhaus, M. (1992). Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxaemia. Journal of Clinical Investigation 90, 533-6.
21. Porteu, F. & Nathan, C. (1990). Shedding of tumor necrosis factor receptors by activated human neutrophils. Journal of Experiments/Medicine 172, 599-607.
22. Cope, A. P., Aderka, D., Wallach, D., Kahan, M., Chu, N. R., Brennan, F. M. et al. (1995). Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF. Immunology 84, 21-30.
23. Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C. & Wallach, D. (1992). Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. Journal of Experimental Medicine 175, 323-9.
24. Exley, A. R., Leese, T., Holliday, M. P., Swann, R. A. & Cohen, J. (1992). Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 33, 1126-8.
25. Grewal, H. P., Kotb, M., el Din, A. M., Ohman, M., Salem, A., Gaber, L. et al. (1994). Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 115,213-21.
26. Norman, J. G., Franz, M. G., Fink, G. S., Messina, J., Fabri, P. J., Gower, W. R. et al. (1995). Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Annals of Surgery 221, 625-34.
27. Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A. et al. (1988). Detection of circulating tumor necrosis factor after endotoxin administration. New England Journal of Medicine 318, 1481-6.
28. Hughes, C. B., Gaber, L. W., Kotb, M., Mohey el Din, A., Pabst, M. & Gaber, A. O. (1995). Induction of acute pancreatitis in germ-free rats: evidence of a primary role for tumor necrosis factor-alpha. Surgery 117, 201-5.
29. Norman, J. G., Fink, G. W. & Franz, M. G. (1995). Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Archives of Surgery 130, 966-70.
30. Formela, L. J., McLaughlin, P. J., Flanagan, B. F., Southern, S. N., Giles, T. E., McDicken, I. F. et al. (1994). Demonstration of tumour necrosis factor in pancreatic acinar cells by in situ hybridisation in a model of acute pancreatitis. Gut 35, A575.
31. Grewal, H. P., Mohey el Din, A., Gaber, L, Kotb, M. & Gaber, A. O. (1994). Amelioration of the physiologic and biochemical changes of acuta pancreatitis using an anti-TNF-alpha polyclonal antibody. American Journal of Surgery 167, 214-9.
32. Mizel, S. B. (1990). How does interleukin 1 activate cells? Cyclic AMP and interleukin 1 signal transduction. Immunology Today 11, 390-1.
33. Okusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J. & Dinarello, C. A. (1988). Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. Journal of Clinical Investigation 81, 1162-72.
34. Weinberg, J. R., Boyle, P., Meager, A. & Guz, A. (1992). Lipopolysaccharide, tumor necrosis factor, and interleukin-1 interact to cause hypotension. Journal of Laboratory and Clinical Medicine 120, 205-11.
35. Tanaka, N., Murata, A., Uda, K., Toda, H., Kato, T., Hayashida, H. et at. (1995). Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model. Critical Care Medicine 23, 901-8.
36. Fisher, C. J., Dhainaut, J. F. A., Opal, S. M., Pribble, J. P., Balk, R. A., Slotman, G. J. et al. (1994). Recombinant interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Journal of the American Medical Association 271, 1836-43.
37. Mayer, A. D., McMahon, M. J., Bowen, M. & Cooper, E. H. (1984). C reactive protein: an aid to assessment and monitoring of acute pancreatitis. Journal of Clinical Pathology 37, 207-11.
38. Wilson, C., Heads, A., Shenkin, A. & lmrie, C. W. (1989). C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. British Journal of Surgery 76,177-81.
39. Taga, T., Hibi, M., Hirata, Y., Yamsaki, K., Yasukawa, K., Matsuda, T. et al. (1989). lnterleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58, 573-81.
40. Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T. & Kishimoto, T. (1990). Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63, 1149-57.
41. 2-IFN/IL-6 in man. Journal of Immunology 142, 2321-4.
42. Reinhart, K., Wiegand-Lohnert, C. & Grimminger, F., Kaul, M., Withington, S., Treacher, D. et al. (1996). Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. Critical Care Medicine 24, 733-42.
43. Borrelli, E., Roux-Lombard, P., Grau, G. E., Giardin, E., Ricou, B., Dayer, J. et al. (1996). Plasma concentrations of cytokines, their soluble receptors, antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Critical Care Medicine 24,392-7.
44. Leser, H. G., Gross, V., Scheibenbogen, C., Heinisch, A., Salm, R., Lausen, M. et al. (1991). Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 101, 782-5.
45. Heath, D. I., Cruickshank, A., Gudgeon, M., Jehanli, A., Shenkin, A. & lmrie, C. W. (1993). Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 34, 41-5.
46. Baggiolini, M., Walz, A. & Kunkel, S. L (1989). Neutrophilactivating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. Journal of Clinical Investigation 84, 1045-9.
47. Spiegel, A. M. (1992). G proteins in cellular control. Current Opinion in Cell Biology 4, 203-11.
48. Rinderknecht, H. (1988). Fatal pancreatitis, a consequence of excessive leukocyte stimulation? International Journal of Pancreatology 3, 105-12.
49. Hack, C. E., Hart, M. & van Schijndel, R. J., Eerenberg, A. J., Nuijens, J. H., Thijs, L. G. et al. (1992). lnterleukin-8 in sepsis: relation to shock and inflammatory mediators. Infection and Immunity 60, 2835-42.
50. Van Zee, K. J., Fischer, E., Hawes, A. S., Herbert, C. A., Terrell, T. G., Baker, J. B. et al. (1992). Effects of intravenous IL-8 administration in non-human primates. Journal of Immunology 148, 1746-52.
51. Gross, V., Andreesen, R., Leser, H. G., Ceska, M., Liehl, E., Lausen, M. et al. (1992). lnterleukin-8 and neutrophil activation in acute pancreatitis. European Journal of Clinical Investigation 22, 200-3.
52. Waldmann, T. A. (1991). The interleukin-2 receptor. Journal of Biological Chemistry 266, 2681-4.
53. Wood, J. J., Rodrick, M. L., O'Mahoney, J. B., Palder, S. B., Saporoschetz, I., D'Eon, P. et al. (1984). Inadequate interleukin-2 production: a fundamental immunological deficiency in patients with major burns. Annals of Surgery 200, 311-9.
54. Moss, N. M., Gough, D. B., Jordan, A. L, Grbic, J. T., Wood, J. J., Rodrick, M. L. et al. (1988). Temporal correlation of impaired immune response after thermal injury with susceptibilty to infection in a murine model. Surgery 104, 882-7.
55. Gough, D. B., Moss, N. M., Jordan, A. L., Grbic, J. T., Rodrick, M. L. & Mannick, J. A. (1988). Recombinant interleukin-2 (rlL-2) improves immune response and host resistance to septic challenge in thermally injured mice. Surgery 104, 292-300.
56. Curley, P., Nestor, M., Collins, K., Saporoschetz, I., Mendez, M., Mannick, J. A. et al. (1996). Decreased interleukin-2 production in murine acute pancreatitis: potential for immunomodulation. Gastroenterology 110, 583-8.
57. Parillo, J. E., Parker, M. M., Natanson, C., Suffredini, A. F., Danner, R. L., Cunnion, R. E. et al. (1990). Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Annals of Internal Medicine 113, 227-42.
58. Guidet, B., Barakett, V., Vassal, T., Petit, J. C. & Offenstadt, G. (1994). Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit. Chest 106, 1194-201.
59. Windsor, J. A., Fearon, K. C. H., Ross, J. A., Barclay, G. R., Smyth, E., Poxton, I. et al. (1993). Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. British Journal of Surgery 80, 1042-6.
60. Lo, C. W. & Walker, W. A. (1989). Changes in the gastrointestinal tract during enteral or parenteral feeding. Nutrition Reviews 47, 193-8.
61. van der Hülst, R. R. W. J., van Kreel, B. K., von Meyenfeldt, M. F., Brummer, R. J., Arends, J. W., Deutz, N. E. et al. (1993). Glutamine and the preservation of gut integrity. Lancet 341, 1363-5.
62. Guedon, C., Schmilz, J., Lerebours, E., Metayer, J., Audran, E., Hemet, J. et al. (1986). Decreased brush border hydrolase activities without gross morphologic changes in human intestinal mucosa after prolonged total parenteral nutrition of adults. Gastroenterology 90, 373-8.
63. Alverdy, J. C., Aoys, S. E. & Moss, G. S. (1988). Total parenteral nutrition promotes bacterial translocation from the gut. Surgery 104, 185-90.
64. O'Riordain, M. G., Fearon, K. C. H., Ross, J. A., Rogers, P., Falconer, J. S., Bartolo, D. C. et al. (1994). Glutamine-supple merited total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Annals of Surgery 220, 212-21.
65. 2 in acute pancreatitis. Scandinavian Journal of Gastroenterology 23, 897-904.
66. 2 in the pathobiology of disease. Laboratory Investigation 55, 391-404.
67. 2 in human acute pancreatitis. Gastroenterology 97, 1521-6.
68. 2 in serum samples from patients with severe acute pancreatitis. Gut 34, 1133-6.
69. Aho, H. J., Ahola, R. A., Tolvanen, A. M. & Nevalainen, T. J. (1983). Experimental pancreatitis in the rat. Changes in pulmonary phospholipids during sodium tauracholate induced acute pancreatitis. Research in Experimental Medicine 182, 79-84.
70. 2 activity in acute pancreatitis. British Journal of Surgery 79, 800-1.
71. Vadas, P. (1984). Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock. Journal of Laboratory and Clinical Medicine 104, 873-81.
72. Fink, M. P. (1998). Therapeutic options directed against platelet activating factor, eicosanoids, and bradykinin in sepsis. Journal of Antimicrobial Chemotherapy 41, Suppl. A, 81-94.
73. Benveniste, J., Henson, P. M. & Cochrane, C. G. (1972). Leukocyte-dependent histamine release from rabbit platelets: the role of IgE, basophils and a platelet-activating factor. Journal of Experimental Medicine 136, 1356-77.
74. Camussi, G., Tetta, C., Bussolino, F., Caligaris-Cappio, F., Coda, R., Masera, C. et al. (1981). Mediators of immune complex induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune induced aggregation. International Archives of Allergy and Applied Immunology 64, 25-41.
75. Humphrey, D. M., McManus, L. M., Satouchi, K., Hanahan, D. J. & Pinckard, R. N. (1982). Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues. Laboratory Investigation 46, 422-7.
76. Konturek, S. J., Dembinski, A., Konturek, P. J., Warzecha, Z., Jaworek, J., Gustaw, P. et al. (1992). Role of platelet activating factor in pathogenesis of acute pancreatitis in rats. Gut 33, 1268-74.
77. Emanuelli, G., Montrucchio, G., Gaia, E., Dughera, L., Corvetti, G. & Gubetta, L. (1989). Experimental acute pancreatitis induced by platelet activating factor in rabbits. American Journal of Pathology 134, 315-26.
78. Zhou, W., Levine, B. A. & Olson, M. S. (1993). Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperStimulation. American Journal of Pathology 142, 1504-12.
79. Ais, G., Lopez-Farre, A., Gomez-Garre, D. N., Novo, C., Romeo, J. M., Braquet, P. et al. (1992). Role of platelet-activting factor in hemodynamic derangements in an acute rodent pancreatic model. Gastroenterology 102, 181-7.
80. Zhou, W., McCollum, M. O., Levine, B. A. & Oison, M. S. (1992). Role of platelet activating factor in pancreatitis associated acute lung injury in the rat. American Journal of Pathology 140, 971-9.
81. Kingsnorth, A. N., Galloway, S. W. & Formela, L. J. (1995). Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. British Journal of Surgery 82, 1414-20.
82. Broe, P. J., Zuidema, G. D. & Cameron, J. L. (1982). The role of ischemia in acute pancreatitis: Studies with an isolated perfused canine pancreas. Surgery 91, 377-82.
83. Warshaw, A. L & O'Hara, P. J. (1978). Susceptibility of the pancreas to ischémie injury in shock. Annals of Surgery 188, 197-201.
84. Thai, A. P., Kobold, E. E. & Hollenberg, M. J. (1963). The release of vasoactive substances in acute pancreatitis. American Journal of Surgery 105, 708.
85. Ofstad, E. (1970). Formation and destruction of plasma kinins during experimental acute haemorrhagic pancreatitis. Scandinavian Journal of Gastroenterology, Suppl. 5, 1-44.
86. Yotsumoto, F., Manabe, T. & Ohshio, G. (1993). Bradykinin involvement in the aggravation of acute pancreatitis in rabbits. Digestion 54, 224-30.
87. Yotsumoto, F., Manabe, T., Ohshio, G., lmanishi, K., Ando, K., Kyogoku, T. et al. (1993). Role of pancreatic blood flow and vasoactive substances in the development of canine acute pancreatitis. Journal of Surgical Research 55, 531-6.
88. Griesbacher, T. & Lembeck, F. (1992). Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis. British Journal of Pharmacology 107, 356-60.
89. Beger, H. G., Birtner, R., Buchler, M., Hess, W. J. E. S. & Schmilz, J. E. (1986). Hemodynamic data pattern in patients with acute pancreatitis. Gastroenterology 90, 74-9.
90. Ito, K., Ramirez-Schon, G., Shah, P. M., Agarwal, N., Delguercio, L. R. M. & Reynolds, B. (1981). Myocardial function in acute pancreatitis. Annals of Surgery 194, 85-8.
91. Shoemaker, W. C., Appel, P. L., Kram, H. B., Bishop, M. H. & Abraham, E. (1993). Temporal hemodynamic and oxygen transport patterns in medical patients: septic shock. Chest 104, 1529-36.
92. London, N. J. M., Neoptolemos, J. P., Lavelle, J., Bailey, I. & James, D. (1989). Contrast-enhanced abdominal computed tomography scanning and prediction of severity of acute pancreatitis: a prospective study. British Journal of Surgery 76, 268-72.
93. Beger, H. G., Bittner, R., Block, S. & Buchler, M. (1986). Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 91, 433-8.
94. Bassi, C., Falconi, M., Girelli, R., Nifosi, F., Elio, A., Martini, N. et al. (1989). Microbiological findings in severe acute pancreatitis. Surgical Research Communications 5, 1-4.
95. Renner, I. G., Savage, W. T., Pantoja, J. L. & Renner, V. J. (1985). Death due to acute pancreatitis: a retrospective analysis of 405 autopsy cases. Digestive Diseases and Sciences 30, 1005-18.
96. Bassi, C., Vesentini, S., Nifosi, F., Girelli, R., Falconi, M., Elio, A. et al. (1990). Pancreatic abscess and other pus-harboring collections related to pancreatitis: a review of 108 cases. World Journal of Surgery 14, 505-12.
97. Widdison, A. L. & Karanjia, N. D. (1993). Pancreatic infection complicating acute pancreatitis. British Journal of Surgery 80, 148-54.
98. Bradley, E. L. (1993). A clinically based classification system for acute pancreatitis. Summary of the international symposium on acute pancreatitis, Atlanta, GA, September 11-13, 1992. Archives of Surgery 128, 586-90.
99. Finch, W. T., Sawyers, J. L. & Schenker, S. (1976). A prospective study to determine the efficacy of antibiotics in acute pancreatitis. Annals of Surgery 183, 667-71.
100. Howes, R., Zuidema, G. D. & Cameron, J. L. (1975). Evaluation of prophylactic antibiotics in acute pancreatitis. Journal of Surgical Research 18, 197-200.
101. Foitzik, T., Mithofer, K., Ferraro, M. J., Fernandez-del-Castillo, C., Lewandrowski, K. B., Rattner, D. W. et al. (1994). Time course of bacterial infection of the pancreas and its relation to disease severity in a rodent model of acute necrotizing pancreatitis. Annals of Surgery 220, 193-8.
102. Mithofer, K., Fernandez-del Castillo, C., Ferraro, M. J., Lewandrowski, K., Rattner, D. W. & Warshaw, A. L. (1996). Antibiotic treatment improves survival in experimental acute necrotizing pancreatitis. Gastroenterology 110, 232-40.
103. Luiten, E. J. T., Hop, W. C. J., Lange, J. F. & Bruining, H. A. (1995). Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Annals of Surgery 222, 57-65.
104. Sainio, V., Kemppainen, E., Puolakkainen, P., Taavitsainenen, M., Kivisaari, L., Valtonen, V. et al. (1995). Early antibiotic treatment in acute necrotising pancreatitis. Lancet 346, 663-7.